Flagship unveils Mirai Bio, an open end-to-end platform company for co-creation of #GeneticMedicines. With its rapid, machine learning platform, biotech partners can accelerate development of their novel genetic medicines. #FlagshipFounded Read the full announcement: https://bit.ly/4dgVxBK
Flagship Pioneering
Biotechnology Research
Cambridge, MA 103,443 followers
We are a biotechnology company that invents and builds platform companies that change the world.
About us
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple transformative human health and sustainability products. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises over 40 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, and Tessera Therapeutics.
- Website
-
http://www.flagshippioneering.com
External link for Flagship Pioneering
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Cambridge, MA
- Type
- Privately Held
- Founded
- 2000
- Specialties
- life sciences, biotech, therapeutics, diagnostics, sustainability, climate change, artificial intelligence, machine learning, agtech, medicines, therapeutics, biology, entrepreneurship, biotechnology, science, innovation, and ventures
Locations
-
Primary
55 Cambridge Parkway
Suite 800E
Cambridge, MA 02142, US
Employees at Flagship Pioneering
-
Karim Lakhani
Professor Harvard Business School | Chair D^3 Institute at Harvard | Board Member, Mozilla Corporation & VideaHealth | Academic Partner, Flagship…
-
Venu Nagali
Strategy, Business Development & Finance Executive ✦ Increase Enterprise Value through Innovative Strategies and Building Results-Producing Teams
-
Susan Vidal
Strategic HR Leader & Aspiring Executive Coach
-
David Khougazian
Executive Partner at Flagship Pioneering
Updates
-
Andre Andonian, Flagship Chair of Asia Pacific and Senior Advisor, joins #FlagshipFounded Invaio as Chairman of the Board of Directors.
We’re delighted to welcome Andre Andonian as the new Chairman of our Board of Directors. We look forward to working with André to accelerate the leap to nature-positive #agriculture with biological crop protection products that are effective and reliable alternatives for farmers. https://lnkd.in/ep42PpAY
-
Flagship and A*STAR - Agency for Science, Technology and Research announce partnership to spur biotech innovation in Singapore. Read the full announcement: https://bit.ly/4gMYAVf
-
Flagship Pioneering reposted this
Thrilled to announce our #medSCAI24 keynote panel: “Identifying and Solving the Hard Challenges to Realizing the Full Translational Impact of AI on Drug Discovery/Development.” Moderated by Endpoints News’ Sr. Science Correspondent Ryan Cross, panelists include Jen Nwankwo, Ph.D. of 1910 Genetics, Rory Kelleher of NVIDIA, Peter Clark, PhD of Novo Nordisk, Caroline Gubser Keller of Novartis and Cameron Trenor, MD of Cellarity, who will discuss how to push the applications of AI and ML in medicine forward. Register today ➡️ https://bit.ly/3yOdJEL #BiggerLeaps
-
#FlagshipFounded Valo Health announces that #Logica, the company's joint AI-powered drug discovery offering with Charles River Laboratories, has entered a collaboration with Lundbeck to progress brain disease research.
We are thrilled to announce #Logica, our joint offering with Charles River Laboratories, has entered a multi-year collaboration with Lundbeck. This new endeavor will leverage Logica to apply its integrated AI-powered solutions in designing small molecule drugs for high unmet need neurological diseases.
-
#FlagshipFounded Moderna welcomes Abbas Hussain to the company’s Board of Directors.
We announced today that Abbas Hussain, former Chief Executive Officer of Vifor Pharma, will join Moderna’s Board of Directors, effective October 2, 2024. Learn more: https://lnkd.in/gApv9j3T
-
#FlagshipFounded Apriori Bio welcomes Harry Kleanthous as Chief Scientific Officer.
Join us in welcoming Harry Kleanthous to the Apriori team as our Chief Scientific Officer. Harry's 30+ years of experience and leadership at biotech and large biopharma companies will be a tremendous asset as we work to better protect humanity against rapidly-evolving viruses. Learn more about what he brings to our team: https://lnkd.in/e8e-c6GV #FlagshipFounded
-
Congratulations to Mark Berry, Chief People Officer at #FlagshipFounded Inari, on being recognized as a Top HR Leader by Visier Inc.
We are proud to present the 2025 Top 50 HR Leaders—a remarkable group of data-driven innovators reshaping the future of human resources across five continents and ten major global industries 👏🏆 These visionary leaders are not only spearheading their organizations' HR functions but also driving excellence in analytics, innovation, talent strategy, technology, and operations. They embody the transformative power of data and technology, revolutionizing how we manage and support workforces globally. 💫🌍 Congratulations to the class of 2025! 🥳 https://lnkd.in/gkXMV6Sx Adam McKinnon, PhD. Aileen Tan Alan Susi Angela Lane Amy Ariano Andrea Kasper Pazinko Angela LE MATHON Annalyn Jacob, Ph.D. Brad Woodfield Casey Fisher Chris M. David Hashemi Dawn Klinghoffer Doug Shagam Eric Bain Erik Otteson Gary Russo Greg Till Heike Prinz Ian Bailie Jaclyn Lee PhD and IHRP-MP (Continued in comments) #hrleaders #hrinnovation
-
Learn more about what it’s like to work as a scientist at Pioneering Medicines, Flagship’s in house drug discovery and development unit. Associate Scientist Anna-Nicole Bosco shares a bit about her role, the collaborative work environment, and what makes working at Pioneering Medicines unique. See open roles on the Pioneering Medicines team: https://bit.ly/3VDclNC
"The Flagship model couples the resources and expertise of industry with the curiosity of academia. Pioneering Medicines is a great example of this. We've established ourselves as a strong research unit, but our strength comes from our ability to collaborate." ➡ Read more about Anna-Nicole Bosco, Associate Scientist at Pioneering Medicines, including her role in understanding the translatability of our therapies directly to the clinic. The latest installment in our 🌟employee spotlight series🌟, introducing you to the team members that are working tirelessly to improve human health and the sustainability of our planet. #WeAreFlagship
-
#FlagshipFounded Moderna announces the first participant dosed in its Phase 3 trial of investigational mRNA Norovirus vaccine.
We announced today that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403. Global recruitment for the Nova 301 trial has also begun. Read more: https://lnkd.in/erhMAGpn